MacroGenics Inc at JMP Securities Life Sciences Conference Transcript
Thanks. Welcome back. It's my pleasure to host Scott Koenig, CEO of MacroGenics. Thanks for joining us today.
Oh, Silvan, it's a real pleasure. Thank you for the invitation.
Questions & Answers
Yeah, thanks. So maybe I want to start off, just to remind the investors -- they're not as familiar with the story. You have a very broad pipeline. Could you just tell us -- and you have an approved medicine. So maybe you could just briefly tell us about -- quickly -- your pipeline and also what the unique capabilities are of the company in regards to antibody design.
My pleasure. So MacroGenics is a company that's been in existence since 2000 -- over 20 years of operation. We built this company from the ground up as a -- focused on immune-based
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
